Van epigenetische programmering tot polyfenomologische herprogrammering, van conceptie tot volwassenheid en ouderdom
Hoe ziekten ontstaan en kunnen voorkomen worden

Epigenetica is een relatief jonge wetenschap: pas recent is men zich bewust geworden van het feit dat genen nauwelijks veranderen, de mutatiesnelheid is in de loop van de evolutie immers verschrikkelijk traag. Het is de expressie van de genen, het al of niet ‘aanzetten’
of ‘afzetten’ ervan, die onze fysiologie en pathologie bepalen.

De reden (en de oplossing) voor ziekten ligt in het antropologisch verleden: zo’n 95 % van de ziekten zouden vroeg in het leven bepaald worden, heel vroeg, vaak zelfs voor de geboorte. En dan dringt zich natuurlijk de vraag op: kunnen we nog iets doen aan epigenetisch geprogrammeerde risico’s? Leef- en eetstijl zijn cruciale factoren om deze te voorkomen. Maar er zijn nog mogelijkheden: polyfenomologische therapie kan soms later in het leven dingen herstellen die vroeger/vroeg in het leven verkeerd gingen.

Polyfenomologie is de preventie-behandeling van de toekomst, maar is thans nog nauwelijks bekend.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Auteur

Leo Pruimboom
Marleen Nys

Trefwoorden:

Figuren

Verschenen in

Referenties

  1. Pruimboom L. Een nieuw behandelingsmodel voor niet-infectieuze ziekten. AT&A 2013; 4:10-15.

  2. Pruimboom L. Nascholingen kPNI. Natura foundation.nl

  3. Ruiz-Núñez B, Pruimboom L, Dijck-Brouwer DA, Muskiet FA. Lifestyle and nutritional imbalances associated with Western diseases: causes and consequences of chronic systemic low-grade inflammation in an evolutionary context. J Nutr Biochem. 2013 Jul;24(7):1183-201. d

  4. Bosma-den Boer MM, van Wetten ML, Pruimboom L. Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering. Nutr Metab (Lond). 2012 Apr 17;9(1):32.

  5. Martin-Gronert MS, Ozanne SE. Mechanisms underlying the developmental origins of disease. Rev Endocr Metab Disord. 2012 Jun;13(2):85-92.

  6. Lillycrop KA, Burdge GC. Epigenetic mechanisms linking early nutrition to long term health. Best Pract Res Clin Endocrinol Metab. 2012 Oct;26(5):667-76.

  7. Boekelheide K et al. Predicting later-life outcomes of early-life exposures. Environ Health Perspect. 2012 Oct;120(10):1353-61.

  8. Thompson RF, Einstein FH. Epigenetic basis for fetal origins of age-related disease. J Womens Health (Larchmt). 2010 Mar;19(3):581-7.

  9. Walker CL, Ho SM. Developmental reprogramming of cancer susceptibility. Nat Rev Cancer. 2012 Jun 14;12(7):479-86.

  10. Tarry-Adkins JL, Ozanne SE. Mechanisms of early life programming: current knowledge and future directions. Am J Clin Nutr. 2011 Dec;94(6 Suppl):1765S-1771S.

  11. Chmurzynska A. Fetal programming: link between early nutrition, DNA methylation, and complex diseases. Nutr Rev. 2010 Feb;68(2):87-98.

  12. Burdge GC, Hanson MA, Slater-Jefferies JL, Lillycrop KA. Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br J Nutr. 2007 Jun;97(6):1036-46.

  13. Liotto N et al. Early nutrition: the role of genetics and epigenetics. Pediatr Med Chir. 2009 Mar-Apr;31(2):65-71.

  14. Reusens B, Theys N, Dumortier O, Goosse K, Remacle C. Maternal malnutrition programs the endocrine pancreas in progeny. Am J Clin Nutr. 2011 Dec;94(6 Suppl):1824S-1829S.

  15. Theys N, Ahn MT, Bouckenooghe T, Reusens B, Remacle C. Maternal malnutrition programs pancreatic islet mitochondrial dysfunction in the adult offspring. J Nutr Biochem. 2011 Oct;22(10):985-94.

  16. Zeng CJ, Zhang L, Yang HX. Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance. Zhonghua Fu Chan Ke Za Zhi. 2010 Sep;45(9):658-63.

  17. Reynolds RM. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner. Psychoneuroendocrinology. 2013 Jan;38(1):1-11.

  18. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav. 2011 Mar;59(3):279-89.

  19. Jiang X, Caudill MA et al. Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. FASEB J. 2012 Aug;26(8):3563-74.

  20. Wilkinson J. High maternal choline intake may prevent the development of stress-related disorders through epigenetic mechanisms. Epigenomics 10/2012; 4(5) 479-80.

  21. Clark PM. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur J Pediatr. 1998 Jan;157 Suppl 1:S7-10.

  22. Bateson P. The impact of the organism on its descendants. Genet Res Int. 2012;2012:640612.

  23. Zambrano E. The transgenerational mechanisms in developmental programming of metabolic diseases. Rev Invest Clin. 2009 Jan-Feb;61(1):41-52.

  24. Aerts L, Van Assche FA. Animal evidence for the transgenerational development of diabetes mellitus. Int J Biochem Cell Biol. 2006;38(5-6):894-903.

  25. Walker CL, Ho SM. Developmental reprogramming of cancer susceptibility. Nat Rev Cancer. 2012 Jun 14;12(7):479-86.

  26. Lillycrop KA. Effect of maternal diet on the epigenome: implications for human metabolic disease. Proc Nutr Soc. 2011 Feb;70(1):64-72.

  27. Canani RB et al. Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev. 2011 Dec;24(2):198-205.

  28. Guilloteau P, Zabielski R, Hammon HM, Metges CC. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol. 2009 Oct;60 Suppl 3:17-35

  29. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab. 2010 Apr;21(4):199-205.

  30. Hanson M et al. Developmental plasticity and developmental origins of non-communicable disease: theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol. 2011 Jul;106(1):272-80.

  31. Lillycrop KA, Burdge GC. Epigenetic changes in early life and future risk of obesity. Int J Obes (Lond). 2011 Jan;35(1):72-83.

  32. Brown DW et al. Adverse childhood experiences and the risk of premature mortality. Am J Prev Med. 2009 Nov;37(5):389-96.

  33. Kelly-Irving M et al. Childhood adversity as a risk for cancer: findings from the 1958 British birth cohort study. BMC Public Health. 2013 Aug 19;13(1):767.

  34. Reiser SJ et al. Adverse childhood experiences and health anxiety in adulthood. Child Abuse Negl. 2013 Sep 5. pii: S0145-2134(13)00225-1.

  35. Schilling EA, Aseltine RH Jr, Gore S. Adverse childhood experiences and mental health in young adults: a longitudinal survey. BMC Public Health. 2007 Mar 7;7:30.

  36. De Venter M, Demyttenaere K, Bruffaerts R. The relationship between adverse childhood experiences and mental health in adulthood. A systematic literature review. Tijdschr Psychiatr. 2013;55(4):259-68.

  37. Neigh GN, Gillespie CF, Nemeroff CB. The neurobiological toll of child abuse and neglect. Trauma Violence Abuse. 2009 Oct;10(4):389-410.

  38. Van Voorhees E, Scarpa A. The effects of child maltreatment on the hypothalamic-pituitary-adrenal axis. Trauma Violence Abuse. 2004 Oct;5(4):333-52.

  39. Nys M. Vitamine K en de synergie tussen vetoplosbare vitaminen. AT&A 2012; 4:40-5.

  40. Kidd PM. Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy. Altern Med Rev. 2010 Sep;15(3):199-222.

  41. Shivananjappa MM, Muralidhara. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model. Reprod Biomed Online. 2012 May;24(5):558-66.

  42. Runsten S et al. Can social support alleviate inflammation associated with childhood adversities? Nord J Psychiatry. 2013 Apr 30. [Epub ahead of print]

  43. Fehér J, Kovács I, Corrado BG. Cod liver oil. A natural Vitamin D for preserving health. Orv Hetil. 2011 Feb 27;152(9):323-30.

  44. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia. 2000 Sep;43(9):1093-8.

  45. Norwegian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr. 2003 Dec;78(6):1128-34.

  46. Jansen D, Kiliaan AJ et al. Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice. PLoS One. 2013 Sep 24;8(9):e75393.

  47. van der Beek EM, Kamphuis PJ. The potential role of nutritional components in the management of Alzheimer's Disease. Eur J Pharmacol. 2008 May 6;585(1):197-207.

  48. Broersen LM, Kiliaan AJ et al. A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice. J Alzheimers Dis. 2013;33(1):177-90.

  49. Hooijmans CR, Kiliaan AJ et al. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis. 2009 Mar;33(3):482-98.

  50. Lim GP et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005 Mar 23;25(12):3032-40.

  51. Pruimboom L, Nys M. Een nieuw behandelingsmodel voor niet-infectieuze ziekten. AT&A 2013; 4:10-15.

Gerelateerde artikelen

Benzodiazepinen niet geschikt bij trauma
Vroege stress beïnvloedt latere psychische gezondheid
Hoge dosis vitamine D als medicijn tegen vitiligo en psoriasis
Genen reguleren hartritme en bloeddruk
Omega-3 tegen neuropathie